JUNS JUPITER NEUROSCIENCES, INC.

NEUTRAL Impact: 3/10 EFFECT
Horizon weeks Filed Apr 27, 2026 Processed 1mo ago SEC 9999999995-26-001329
IPO/offering going effective
Latest settled — T+20d
JUNS ▼ -36.64% at T+20d
NEUTRAL call ✗ call lost -36.64% · α vs SPY -41.60% · entry $0.3630 → $0.2300
Next anchor: T+60d in 5w
Last close $0.2390 (close Jun 12) · -34.16% from $0.3630 entry
Entry anchored
Apr 24, 01:14 PM ET
via Databento tick
T+1d
+1.38%
call +1.38% · α +1.86%
$0.3680
settled 7w ago
T+5d
+11.02%
call +11.02% · α +10.62%
$0.4030
settled 6w ago
T+20d
-36.64%
call -36.64% · α -41.60%
$0.2300
settled 20d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

Jupiter Neurosciences' S-3 shelf registration has become effective, allowing the company to issue unspecified amounts of securities from time to time. This follows an earlier S-1 filing, but the current effective registration is for a shelf offering, not an IPO.

Actionable Insight

Monitor for future prospectus supplements that will disclose specific offering terms, size, and pricing. Until then, the market impact is limited to the overhang of potential dilution.

Key Facts

  • S-3 shelf registration (File No. 333-295085) became effective on April 24, 2026
  • The shelf allows for the issuance of unspecified amounts of securities over time
  • This is not an IPO — the earlier S-1 filing was superseded or separate; this EFFECT notice is for the S-3
  • Company is a clinical-stage biopharma firm with no commercial products yet

Financial Impact

Potential for future dilution depending on issuance size and pricing, which are not disclosed

dilutionequitymarket cap

Risk Factors

  • Future share dilution when securities are issued under the shelf
  • Downward pressure on stock price if offerings occur in a weak market

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001329
Document: 9999999995-26-001329-index.html9999999995-26-001329
Document: 9999999995-26-001329.txt9999999995-26-001329
3 reports for JUNS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for JUNS — sortable, filterable
Type Now
May 21, 2026
24d ago
8-K
BEARISH ★ 6/10
$0.2710 $0.2900▼ −7.01%▼ −5.41%$0.2390 (+11.81%)
May 21, 2026
24d ago
424B5
BEARISH ★ 6/10
$0.2710 $0.2900▼ −7.01%▼ −5.41%$0.2390 (+11.81%)
Apr 27, 2026
7w ago
EFFECT
NEUTRAL ★ 3/10
$0.3630 $0.4030▲ +11.02%▲ +10.62%$0.2390 (−34.16%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 4h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access